This activation leads to the upregulation of various cytoprotective and antioxidant proteins
Nothing more complicated than that
GLP-1 receptor agonists like Ozempic and Mounjaro have reshaped the conversation around weight loss and diabetes management
These agents include semaglutide (Ozempic for diabetes, Wegovy for obesity), liraglutide (Victoza for diabetes, Saxenda for obesity), dulaglutide (Trulicity, diabetes only), and tirzepatide (Mounjaro for diabetes, Zepbound for obesity)with tirzepatide being a dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 receptor agonist
At exactly 4 days post-missed-dose, roughly 40% of the prior dose remains in circulation
They suggested people taking antiobesity medications add two days of strength training per week to a regimen